Suppr超能文献

大鼠尾动脉中血管加压素-1受体的非竞争性阻断

Noncompetitive blockade of vasopressin-1 receptors in rat tail artery.

作者信息

Fox A W, Karapanos G, Mitch W E

机构信息

Department of Medicine, Harvard Medical School, Boston, Massachusetts.

出版信息

J Pharmacol Exp Ther. 1987 Nov;243(2):598-602.

PMID:2960795
Abstract

To study vasopressin-1 receptor-mediated contraction of the isolated rat tail artery, pseudoirreversible blockade was produced by incubating tissues with 10 nM 1-beta-mercapto,beta,beta,cyclopentamethylene propionic acid, 2(O-me)tyrosine,-8-D-arginine vasopressin and 1.2 mM magnesium. Concentration-response curves to vasopressin agonists were constructed before and during exposure to 1-beta-mercapto,beta,beta,cyclopentamethylene propionic acid, 2(O-me)tyrosine,-8-D-arginine vasopressin, and at three time points after washing out the antagonist. EC50 values (-log M) for arg-vasopressin (AVP, 8.02 +/- 0.16) and arg-vasotocin (AVT, 9.51 +/- 0.12) were unaltered after exposure to the antagonist and washing of the tissues. The control EC50 for lys-vasopressin (LVP, 8.33 +/- 0.09) was significantly lower than after blockade (P less than .05). At each time point after blockade, the intrinsic activity of LVP was greater than either AVP or AVT. Increasing the ambient magnesium ion concentration greater than 1.2 mM did not alter responses to vasopressin agonists. Reducing the ambient magnesium ion from 1.2 mM to zero increased the EC50 values for all vasopressin agonists by 6- to 20-fold, but had no effect on maximal response size, nor on the concentration-response curve for norepinephrine. Pseudoirreversible blockade performed in the absence of magnesium also increased the EC50 for LVP but not for AVP or AVT after exposure to the antagonist. We conclude that LVP has greater efficacy than AVP and AVT at vasopressin receptors in rat tail artery, and that magnesium ions affect only agonist affinity but not efficacy at this vasopressin-1 receptor.

摘要

为研究血管加压素-1受体介导的离体大鼠尾动脉收缩作用,通过将组织与10 nM的1-β-巯基,β,β,环戊亚甲基丙酸、2(O-甲基)酪氨酸、-8-D-精氨酸血管加压素以及1.2 mM镁一起孵育来产生假不可逆性阻断。在暴露于1-β-巯基,β,β,环戊亚甲基丙酸、2(O-甲基)酪氨酸、-8-D-精氨酸血管加压素之前和期间,以及在洗去拮抗剂后的三个时间点,构建对血管加压素激动剂的浓度-反应曲线。暴露于拮抗剂并冲洗组织后,精氨酸血管加压素(AVP,8.02±0.16)和精氨酸催产素(AVT,9.51±0.12)的EC50值(-log M)未改变。赖氨酸血管加压素(LVP,8.33±0.09)的对照EC50显著低于阻断后(P<0.05)。在阻断后的每个时间点,LVP的内在活性均大于AVP或AVT。将环境镁离子浓度增加至大于1.2 mM不会改变对血管加压素激动剂的反应。将环境镁离子浓度从1.2 mM降至零会使所有血管加压素激动剂的EC50值增加6至20倍,但对最大反应大小以及去甲肾上腺素的浓度-反应曲线均无影响。在无镁情况下进行的假不可逆性阻断也会增加暴露于拮抗剂后LVP的EC50,但不会增加AVP或AVT的EC50。我们得出结论,在大鼠尾动脉的血管加压素受体上,LVP比AVP和AVT具有更高的效能,并且镁离子仅影响激动剂亲和力,而不影响该血管加压素-1受体的效能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验